New combo therapy aims to boost immune system's fight against aggressive chest cancer
NCT ID NCT05380713
Summary
This study tested a two-part treatment plan for people with previously untreated malignant mesothelioma. First, it compared two different low-dose radiation treatments given before surgery. After surgery, eligible patients received a combination of two immunotherapy drugs. The goal was to see if this approach could better control the cancer by boosting the body's own immune response against the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA, MALIGNANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.